.png){kind=logo}
Introducing Re:Balans®
A wearable device for hydration monitoring
Featured in
Click logos to view articles
For US Customers and Partners
Re:Balans medical device is currently only available for clinical investigations and research purposes, and not yet cleared for medical use in the EU or US. However, our non-medical variant "Re:Balans Insight" is available for testing by customers and partners.
Hospitals and municipalities
Partners
Defense
Case study
Prioritizing hydration greatly reduces fall rates in the elderly
A hydration project implemented across 33 residential and nursing homes in England (Torbay and South Devon) demonstrated significant improvements in fall rates. Between May 2021 and November 2022, the number of falls requiring a hospital admission fell by 63% and incidences of urinary tract infections requiring antibiotics reduced by 18.5%.
Despite its importance in monitoring patients with fluid management conditions, identifying an effective approach continues to present a challenge in the field of medicine.
Re:Balans medical device is currently only available for clinical investigations and research purposes, and are not yet cleared for medical use in the EU or US.
​
Our Innovation Partners
This project has received funding from the European Union's Horizon 2020 research and development program under grant agreement No 969065.
This project has also received funding from the European Union's Horizon cybersecurity research and development program under grant agreement No 101094323 - NEMECYS, together with SINTEF.
Mode in Numbers
12
Employees
>10M$
Capital invested
>1000
Devices produced for clinical testing
6
Years of development
2
Patents
7
Completed clinical studies
ISO13485
Certification
